Literature DB >> 15023812

Nonconvulsive status epilepticus in patients with cancer: imaging abnormalities.

Adília Hormigo1, Bernardo Liberato, Eric Lis, Lisa M DeAngelis.   

Abstract

BACKGROUND: Convulsive status epilepticus may cause reversible neuroimaging abnormalities. These cortical changes have been reported rarely in association with nonconvulsive status epilepticus.
OBJECTIVE: To describe patients with cancer who had reversible magnetic resonance (MR) imaging abnormalities from nonconvulsive status epilepticus and whose altered mental status and MR imaging findings were initially considered to result from a structural lesion related to their underlying tumor.
DESIGN: Retrospective study.
SETTING: Department of Neurology at Memorial Sloan-Kettering Cancer Center, New York, NY. PATIENTS: Eight patients with a diagnosis of nonconvulsive status epilepticus who underwent MR imaging.
RESULTS: Enhancing cortical abnormalities were observed on MR images in 4 (50%) of 8 patients with cancer who had impaired mental status and an electroencephalogram demonstrating seizure activity. Follow-up MR images showed neuroimaging improvement or resolution in all patients.
CONCLUSIONS: Cortical enhancement on MR images in patients with cancer who have altered mental status may be due to nonconvulsive status epilepticus and not recurrent or metastatic tumor. If electroencephalography is not immediately available at initial evaluation, a trial of anticonvulsant therapy deserves consideration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15023812     DOI: 10.1001/archneur.61.3.362

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  8 in total

1.  Intravenous levetiracetam terminates refractory focal status epilepticus.

Authors:  Nicholas S Abend; Nicole Florance; Richard S Finkel; Daniel J Licht; Dennis J Dlugos
Journal:  Neurocrit Care       Date:  2009       Impact factor: 3.210

2.  Peri-ictal pseudoprogression in patients with brain tumor.

Authors:  Sylvain Rheims; Damien Ricard; Martin van den Bent; Luc Taillandier; Véronique Bourg; Virginie Désestret; Stéphanie Cartalat-Carel; Marc Hermier; Annick Monjour; Jean-Yves Delattre; Marc Sanson; Jérôme Honnorat; François Ducray
Journal:  Neuro Oncol       Date:  2011-07       Impact factor: 12.300

3.  Non-convulsive status epilepticus in brain tumors.

Authors:  M Casazza; I Gilioli
Journal:  Neurol Sci       Date:  2011-11       Impact factor: 3.307

Review 4.  Seizures and epilepsy in cancer patients.

Authors:  Edward K Avila; Jerome Graber
Journal:  Curr Neurol Neurosci Rep       Date:  2010-01       Impact factor: 5.081

5.  Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy.

Authors:  Tyler J Fraum; Teri N Kreisl; Joohee Sul; Howard A Fine; Fabio M Iwamoto
Journal:  J Neurooncol       Date:  2011-04-27       Impact factor: 4.130

6.  Central neurological complications in critically ill patients with malignancies.

Authors:  Stéphane Legriel; Hélène Marijon; Michael Darmon; Virginie Lemiale; Jean-Pierre Bedos; Benoît Schlemmer; Elie Azoulay
Journal:  Intensive Care Med       Date:  2009-11-12       Impact factor: 17.440

7.  Stroke-like migraine attacks after radiation therapy (SMART) syndrome is not always completely reversible: a case series.

Authors:  D F Black; J M Morris; E P Lindell; K N Krecke; G A Worrell; J D Bartleson; D H Lachance
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-20       Impact factor: 3.825

8.  A comparison of anticonvulsant efficacy and action mechanism of Mannitol vs Phenytoin in adult rat neocortical slices.

Authors:  Ruggero Serafini
Journal:  IBRO Rep       Date:  2017-09-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.